About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
56 y/o Female with a History of Hepatitis C, Cirrhosis, Exertional Dyspnea and PAH: Clinical Examination and Treatment Considerations
By
Scripps Health
FEATURING
Rajeev Mohan
,
Ajay Srivastava
,
Thomas Heywood
March 5, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
10:26
Boehringer Ingelheim and Lilly Cardiology
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Rev…
Feat.
J. Butler
Featured Video
08:43
Boehringer Ingelheim and Lilly Cardiology
Considerations for Initiating a SGLT2 Inhibitor in Heart Failure Pat…
Feat.
J. Butler
Related Content
AUTOPLAY
ON
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century …
Feat.
R. DeFronzo
26:01
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…
Feat.
R. DeFronzo
19:40
Sonja Bartolome
PAH Treatment Algorithm
11:37
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…
Feat.
P. Heidenreich
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
17:44
Rita Jermyn
SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease
21:07
Gilead
Combination Therapy in Pulmonary Arterial Hypertension
Feat.
M. Chakinala, MD,
I. Preston, MD
19:30
ACC 2022 Conference Coverage
Hot Topics in Heart Failure ACC.22
Feat.
N. Ibrahim
10:02
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Comb…
Feat.
G. Umpierrez
13:42
George Bakris
Current Status of Prevention and Treatment of Diabetic Nephropathy
35:15
Scripps Health: Fourth Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension
Pulmonary Arterial Hypertension: Who, When and How to Treat?
Feat.
R. Mohan
11:50
American Heart & Vascular Institute
New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …
Feat.
M. Kittleson
12:23
American Heart & Vascular Institute
SGLT2 Inhibitors for HF: Is this Therapy Helpful for Reducing the Ho…
Feat.
M. Tipton
12:22
James Klinger
Drug Therapies for PAH
17:35
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2…
Feat.
B. Greenberg
10:07
Inova Cherry Blossom Cardiovascular Symposium 2022
RV Failure and Pulmonary Hypertension
Feat.
M. Psotka
24:19
University of Virginia School of Medicine and School of Nursing
GLP1-Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes: How …
Feat.
E. Barrett
15:25
Javed Butler
SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus
27:02
16th Annual Mid-Atlantic Hospital Medicine Symposium
Acute Heart Failure and Knowing Medications
Feat.
A. Lala-Trindade
